Effects of drugs on walking after spinal cord injury

Spinal Cord

Volumn 36, Issue 10, 1998, Pages 699-715

  Norman, Kathleen E ^a   Pépin, André ^a   Barbeau, Hugues ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Baclofen; Clonidine; Cyproheptadine; Gait; Spinal cord injuries

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BACLOFEN; CLONIDINE; CYPROHEPTADINE; SEROTONIN ANTAGONIST;

ADULT; ARTICLE; BODY POSTURE; CLINICAL ARTICLE; CLONUS; DISABLED PERSON; DISEASE SEVERITY; DRUG ELIMINATION; HUMAN; MALE; PRIORITY JOURNAL; SPASTICITY; SPINAL CORD INJURY; TREADMILL; WALKING; WALKING AID;

EID: 0031786105     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3100674     Document Type: Article

References (84)

1. Stover SL, Fine PB, eds. Spinal Cord Injury: The Facts and Figures. Birmingham, Alabama: The University of Alabama at Birmingham, 1986.
2. Tator CH et al. Changes in epidemiology of acute spinal cord injury from 1947 to 1981. Surg Neurol 1993; 40: 207-215.
3. Dixon GS, Danesh JN, Caradoc-Davies TH. Epidemiology of spinal cord injury in New Zealand. Neuroepidemiology 1993; 12: 88-95.
4. Knutsdottir S. Spinal cord injuries in Iceland 1973-1989. A follow up study. Paraplegia 1993; 31: 68-72.
5. Shingu H et al. A nationwide epidemiological survey of spinal cord injuries in Japan from January 1990 to December 1992. Paraplegia 1995; 33: 183-188.
6. Silberstein B, Rabinovich S. Epidemiology of spinal cord injuries in Novosibirsk. Russia. Paraplegia 1995; 33: 322-325.
7. Knutsson E, Richards CL. Different types of disturbed motor control in gait of hemiparetic patients. Brain 1979; 102: 405-430.
8. Dietz V, Quintern J, Berger W. Electrophysiological studies of gait in spasticity and rigidity: evidence that altered mechanical properties of muscle contribute to hypertonia. Brain 1981; 104: 431-449.
9. Conrad B, Benecke R, Meinck H-M. Gait disturbances in paraspastic patients. In: Delwaide PJ, Young M (eds.) Clinical Neurophysiology in Spasticity. Contribution to Assessment and Pathophysiology. Amsterdam: Elsevier, 1985; pp 55-174.
10. Fung J, Barbeau H. A dynamic EMG profile to quantify muscular activation disorder in spastic paretic gait. Electroencephalogr Clin Neurophysiol 1989; 73: 233-244.
11. Kerrigan DC, Gronley J, Perry J. Stiff-legged gait in spastic paresis. Am J Phys Med Rehabil 1991; 70: 294-300.
12. Fung J, Stewart JE, Barbeau H. The combined effects of clonidine and cyproheptadine with interactive training on the modulation of locomotion in spinal cord injured subjects. J Neurol Sci 1990; 100: 85-93.
13. Wainberg M, Barbeau H, Gauthier S. The effects of cyproheptadine on locomotion and on spasticity in patients with spinal cord injuries. J Neurol Neurosurg Psychiatry 1990; 53: 754-763.
14. Stewart JE, Barbeau H, Gauthier S. Modulation of locomotor patterns and spasticity with clonidine in spinal cord injured patients. Can J Neurol Sci 1991; 18: 321-332.
15. Dietz V, Colombo G, Jensen L, Baumgartner L. Locomotor capacity of spinal cord in paraplegic patients. Ann Neurol 1995; 37: 574-582.
16. Parke B, Penn RD, Savoy SM, Corcos DM. Functional outcome after delivery of intrathecal baclofen. Arch Phys Med Rehabil 1989; 70: 30-32.
17. Azouvi P et al. Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil 1996; 77: 35-39.
18. Piepmeier JM, Jenkins NR. Late neurological changes following traumatic spinal cord injury. J Neurosurg 1988; 69: 399-402.
19. Ditunno JF Jr, Stover SL, Freed MM, Ahn JH. Motor recovery of the upper extremities in traumatic quadriplegia: a multicenter study. Arch Phys Med Rehabil 1992; 73: 431-436.
20. Norman, KE, Barbeau H. Comparison of the effects of cyproheptadine, clonidine and baclofen on locomotor pattern in individual subjects with spastic paresis. Soc Neurosci Abstr; 1992, 860.
21. Norman KE, Barbeau H. Comparison of cyproheptadine, clonidine and baclofen on the modulation of gait pattern in subjects with spinal cord injury. In: Thilmann AF, Burke DJ, Rymer WZ, eds. Spasticity: Mechanisms and Management, Berlin: Springer-Verlag, 1993; pp 410-425.
22. Norman KE, Barbeau H. Comparison of the effects of cyproheptadine, clonidine and baclofen on gait pattern in subjects with spastic paresis. Can J Rehab 1993; 7: 219-220.
23. Barbeau H, Wainberg M, Finch L. Description and application of a system for locomotor rehabilitation. Med Biol Eng Comput 1987; 25: 341-344.
24. Norman KE, Pepin A, Ladouceur M, Barbeau H. A treadmill apparatus and harness support for evaluation and rehabilitation of gait. Arch Phys Med Rehabil 1995; 76: 772-778.
25. Finch L, Barbeau H, Arsenault BA. Influence of body weight support on normal human gait: development of a gait retraining strategy. Phys Ther 1991; 71: 842-856.
26. Nilsson J, Thorstensson A, Halbertsma J. Changes in leg movements and muscle activity with speed of locomotion and mode of progression in humans. Acta Physiol Scand 1985; 123: 457-475.
27. Winter DA. Biomechanical motor patterns in normal walking. J Motor Behav 1983; 15: 302-330.
28. Saleh JW, Yang MU, van Itallie TB, Hashim SA. Ingestive behavior and composition of weight change during cyproheptadine administration. Int J Obes 1979; 3: 213-221.
29. Kardinal CG et al. A controlled trial of cyproheptadine in cancer patients with anorexia and or cachexia. Cancer 1990; 65: 2657-2662.
30. Young RR, Delwaide PJ. Drug therapy. Spasticity. N Eng J Med 1981; 304: 28-33, 96-99.
31. Whyte J, Robinson KM. Pharmacologic management. In: Glenn MB, Whyte J, (eds.) The Practical Management of Spasticity in Children and Adults. Malvern. Pennsylvania: Lea & Febiger; 1990 pp 201-226.
32. Rossignol S, Chau C, Barbeau H. Pharmacology of locomotion in chronic spinal cats. In: Taylor A, Gladden MH, Durbaba R, (eds.) Alpha and Gamma Motor Systems. New York: Plenum Press, 1996 pp 449-455.
33. Barbeau H, Rossignol S. The effects of serotonergic drugs on the locomotor pattern and on cutaneous reflexes of the adult chronic spinal cat. Brain Res 1990; 514: 55-67.
34. Chau C et al. Effects of GABAergic drugs on locomotion in adult chronic spinal cats. Soc Neurosci Abstr; 1995: 420.
35. Rémy-Neris O et al. The effects of intrathecal clonidine on spinal reflexes and on locomotion in incomplete paraplegic subjects. Abstracts from 2nd Meeting of European Neuroscience, 1996.
36. Broseta J et al. Use of intrathecal baclofen administered by programmable infusion pumps in resistant spasticity. Acta Neurochir Suppl 1989; 46: 39-45.
37. Lazorthes Y et al. Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 1990; 72: 393-402.
38. Penn RD. Intrathecal baclofen for severe spasticity. Ann NY Acad Sci 1988; 531: 157-166.
39. Latash ML, Penn RD, Corcos DM, Gottlieb GL. Effects of intrathecal baclofen on voluntary motor control in spastic paresis. J Neurosurg 1990; 72: 388-392.
40. Loubser PG et al. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia 1991; 29: 48-64.
41. Sahuquillo J et al. Intraspinal haclolen in the treatment of severe spasticitv and spasms. Acta Neurochir (Wien) 1991; 110: 166-173.
42. Saltuari L et al. Indication, efficiency and complications of intrathecal pump supported baclofen treatment in spinal spasticity. Acta Neurol (Napoli) 1992; 14: 187-194.
43. Meythaler JM et al. Intrathecal baclofen in hereditary spastic paraparesis. Arch Phys Med Rehabil 1992; 73: 794-797.
44. Ochs GA. Intrathecal baclofen. Baillères Clin Neurol 1993; 2: 73-86.
45. Abel NA, Smith RA. Intrathecal baclofen for treatment of intractable spinal spastieily. Arch Phys Med Rehabil 1994; 75: 54-58.
46. Campbell SK, Almeida GL, Penn RD, Corcos DM. The effects of intrathecally administered haclolen on function in patients with spasticity. Phys Ther 1995; 75: 352-362.
47. Corston RN, Johnson F, Godwin-Austen RB. The assessment of drug treatment of spastic gait. J Neurol Neurosurg Psychiatry 1981; 44: 1035-1039.
48. Barbeau H, Chau C, Rossignol S. Noradrenergic agonists and locomotor training affect locomotor recovery after cord transection in adult cats. Brain Res Bull 1993; 30: 387-393.
49. Chau C, Barbeau H, Rossignol S. Early locomotor training with clonidine in spinal cats. J Neurophysiol 1998; 79: 392-409.
50. Barbeau H, Julien C, Rossignol S. The effects of clonidine and yohimbine on locomotion and cutaneous reflexes in the adult chronic spinal eat. Brain Res 1987; 437: 83-96.
51. Davidoff RA, Sears S. The effects of Lioresal on synaptic activity in the isolated spinal cord. Neurology 1974; 24: 957-963.
52. Fox S et al. Action of baclofen on mammalian synaptic transmission. Neuroscience 1978; 3: 495-515.
53. Tuckman J, Chu DS, Petrillo CR, Naftchi NE. Clinical trial of an alpha adrenergic receptor stimulating drug (clonidine) for treatment of spasticity in spinal cord injured patients. In: Naftchi NE, (ed.) Spinal Card Injury. New York: SP Medicine & Science Books, 1982: pp 133-137.
54. Donovan YM, Carter RE, Rossi CD, Wilkerson MA. Clonidine effect on spasticity: a clinical trial. Arch Phys Med Rehabil 1988; 69: 193-194.
55. Barbeau H, Richards CL, Bédard PJ. Action of cyproheptadine in spastic paraparetic patients. J Neurol Neurosurg Psychiatry 1982; 45: 923-926.
56. Duncan GW, Shahani BT, Young RR. An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions. Neurology 1976; 26: 441-446.
57. Sachais BA, Logue JN, Carey MS. Baclofen, a new antispastic drug. A controlled, multicenter trial in patients with multiple sclerosis. Arch Neurol 1977; 34: 422-428.
58. Nance PW. A comparison of clonidine, eyproheptadine and baclofen in spastic spinal cord injured patients. J Am Paraplegia Soc 1994; 17: 150-156.
59. Grillner S. Control of locomotion in bipeds, tetrapods and fish. In: Brooks VB, (ed.) Handbook of Physiology, Section I: The Nervous System, Volume II. Motor control. Bethesda, Maryland: American Physiological Society, 1981: pp 1179-1236.
60. Rossignol S. Neural control of stereotypic limb movements. In: Rowell LB, Shepherd JT, (eds.) Handbook of Physiology, Section 12. Exercise: Regulation and Integration of Multiple Systems. Bethesda, Maryland: American Physiological Society, 1996: pp 173-216.
61. Eidelberg E, Walden JG, Nguyen LH. Locomotor control in macaque monkeys. Brain 1981; 104: 647-663.
62. Vilensky JA, Moore AM, Eidelberg E, Walden JG. Recovery of locomotion in monkeys with spinal cord lesions. J Motor Behav 1992; 24: 288-296.
63. Hultborn H, Petersen N, Brownstone R, Nielsen J. Evidence of fictive spinal locomotion in the marmoset (callithrix jacchus). Soc Neurosci Abstr 1993: 539.
64. Bussel B et al. Myoclonus in a patient with spinal cord transection. Possible involvement of the spinal stepping generator. Brain 1988; 111: 1235-1245.
65. Bussel B, Roby-Brami A, Rémy-Néris O, Yakovleff A. Evidence for a spinal stepping generator in man. Paraplegia 1996; 34: 91-92.
66. Calancie B et al. Involuntary stepping alter chronic spinal cord injury: evidence tor a central rhythm generator for locomotion in man. Brain 1994; 117: 1143-1159.
67. Illis LS. Is there a central pattern generator in man? Paraplegia 1995; 33: 239-240.
68. Barbeau H, Bédard PJ. Denervation supersensitivity to 5-hydroxytryptophan in rats following spinal transection and 5,7-dihydroxytryptamine injection. Neuropharmacology 1981; 20: 611-616.
69. Wolpaw JR et al. Adaptive plasticity in the spinal stretch reflex. Brain Res 1983; 267: 196-200.
70. Wolpaw JR. Adaptive plasticity in the spinal stretch reflex: reversal and re-development. Brain Res 1983; 278: 299-304.
71. Wolpaw JR, Braitman DJ, Seegal RF. Adaptive plasticity in the spinal stretch reflex: initial development. J Neurophysiol 1983; 50: 1296-1311.
72. Wolpaw JR. Operant conditioning of primate spinal reflexes: the H-reflex. J Neurophysiol 1987; 57: 443-459.
73. Wolpaw JR, Lee CL, Calaitges JG. Operant conditioning of primate triceps surae H-reflex produces reflex asymmetry. Exp Brain Res 1989; 75: 35-39.
74. Edgerton VR et al. Use-dependent plasticity in spinal stepping and standing. Adv Neurol 1997; 72: 233-247.
75. Edgerton W et al. Does motor learning occur in the spinal cord? Neuroscientist 1997; 3: 287-294.
76. Barbeau H, Rossignol S. Recovery of locomotion after chronic spinalization in the adult cat. Brain Res 1987; 412: 84-95.
77. Lovely RG, Gregor RJ, Roy RR, Edgerton VR. Effects of training on the recovery of full-weight bearing stepping in the adult spinal cat. Exp Neurol 1986; 92: 421-435.
78. Bélanger M, Drew I, Provencher J, Rossignol S. A comparison of treadmill locomotion in adult cats before and after spinal transection. J Neurophysiol 1996; 76: 471-491.
79. Muir GD, Sleeves M. Sensorimotor stimulation to improve locomotor recovery after spinal cord injury. Trends Neurosci 1997; 20: 72-77.
80. Wernig A, Müller S. Lauffland locomotion with body weight support improved walking in persons with severe spinal cord injuries. Paraplegia 1992; 30: 229-238.
81. Barbeau H, Danakas M, Arsenault B. The effects of locomotor training in spinal cord injured subjects A preliminary study. Restor Neurol Neurosci 1993; 5: 81-84.
82. Dietz V, Colombo G, Jensen L, Baumgartner L. Locomotor capacity of spinal cord in paraplegic patients. Ann Neurol 1995; 37: 574-582.
83. Barbeau H, Rossignol S. Enhancement of locomotor recovery following spinal cord injury. Curr Opin Neurol 1994; 7: 517-524.
84. Dietz V, Wirz M, Jensen L. Locomotion in patients with spinal cord injuries. Phys Ther 1997; 77: 508-516.